There was no significant association between LAT1 expression level and other variables (patient gender or age, cell type, cancer stage, IPI or FLIPI2 score, extranodal and bone marrow involvement, cytogenetic abnormality, and hemoglobin level) (Table 4). This evidence concerns the gene SLC7A5 and cancer.